Yong Ben
Chief Medical & Development OfficerDr. Yong Ben is Independent Director of Corbus Pharmaceuticals Holdings, Inc. from March 1 , 2023. Dr. Ben is Director of Corbus Pharmaceuticals, Inc. Dr. Ben is Member of Scientific Advisory Board of Shanghai Allist Pharmaceuticals Co., Ltd. Dr. Ben is Chief Medical & Development Officer of BridgeBio Oncology Therapeutics, Inc. from September 2024. Dr. Ben joined the BridgeBio Oncology Therapeutics, Inc. in September 2024. Dr. Ben was Chief Medical Officer of Solid Tumors of BeOne Medicines AG from November 2021 to February 09, 2022. Dr. Ben was Chief Medical Officer - Immuno-Oncology of BeOne Medicines AG from February 2019 to November 2021. Dr. Ben was employed at BeOne Medicines AG from February 2019 to February 09, 2022. Dr. Ben was Chief Medical Officer of BioAtla, Inc. Dr. Ben joined the BioAtla, Inc. on May 09, 2017. Dr. Ben was Scientific & Clinical Advisor of NKGen Biotech, Inc. Dr. Ben was Member of Scientific Advisory Board of NKGen Biotech, Inc. Dr. Ben has M.B.A. from University of California - San Diego, Bachelor's from Jilin University, M.D. from Jilin University.
Positions
- Company NameBridgeBio Oncology Therapeutics, Inc.Stock CodeBBOTPositionChief Medical & Development OfficerColleagues
